EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Evaluation and comparison of the anti-proliferative and anti-metastatic effects of urolithin A and urolithin B against esophageal cancer cells: an in vitro and in silico study

Maryam Shojaee, Mehdi Rostami, Mohammad Soukhtanloo, Mohammad Jalili-Nik

DARU Journal of Pharmaceutical Sciences · 2025

DOI: 10.1007/s40199-025-00570-1 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift DARU Journal of Pharmaceutical Sciences, 2025. Verfasst von Maryam Shojaee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Coumarins, Esophageal Neoplasms, Antineoplastic Agents. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Esophageal squamous cell carcinoma (ESCC) is a prevalent and lethal cancer, with traditional treatments often ineffective. This study investigates the anti-proliferative and anti-metastatic effects of natural compounds Urolithin A (UA) and Urolithin B (UB) on ESCC cell lines KYSE-30 and YM-1. METHODS: KYSE-30 and YM-1 ESCC cells were treated with UA and UB, and their viability assays, cell cycle arrest, apoptosis, expressions of mRNA linked to apoptosis and metastasis, generation of reactive oxygen species (ROS), activity of MMP-2 and MMP-9, along with mRNA expressions of MMP-2 and MMP-9, and migration were assessed. RESULTS: The results showed that UA (which had lower IC50 than UB) and UB reduced the viability of both KYSE-30 and YM-1 cells. Furthermore, UA and UB exhibited lower toxicity towards normal HFF cells compared to ESCC cells. Both UB and the more effective UA induced apoptosis and caused G2/M cell cycle arrest in KYSE-30 and YM-1 cells. Additionally, UA and UB elevated ROS production and led to a decrease in Bcl-2 expression while increasing the expression of Bax and p21 genes. A decrease in the mRNA expression and enzymatic activity of MMP-2 and MMP-9 was observed following treatment with UA and UB. CONCLUSION: UB and, more potently, UA show the potential to induce apoptosis while reducing metastatic properties and migration of ESCC cells, suggesting them as promising candidates for new anti-ESCC therapies; however, further preclinical and clinical research is needed to fully understand their anti-cancer effects and mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsEsophageal NeoplasmsAntineoplastic AgentsHumansCell Line, TumorCell ProliferationApoptosisReactive Oxygen SpeciesCell MovementMatrix Metalloproteinase 2Matrix Metalloproteinase 9Esophageal Squamous Cell CarcinomaCell Cycle CheckpointsCell SurvivalComputer Simulation

Stichwörter der Autor:innen

ApoptosisEsophageal cancerEsophageal squamous cell carcinomaMatrix metalloproteinaseMigrationUrolithin AUrolithin B

Substanzen

Coumarins3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneReactive Oxygen SpeciesMatrix Metalloproteinase 2Matrix Metalloproteinase 9urolithin BMMP9 protein, humanMMP2 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Soukhtanloom@mums.ac.ir.
  • Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. Soukhtanloom@mums.ac.ir.
  • Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Mohammad.Jalilinik@gmail.com.
  • Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. Mohammad.Jalilinik@gmail.com.

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Shojaee, M., Rostami, M., Soukhtanloo, M., & Jalili-Nik, M. (2025). Evaluation and comparison of the anti-proliferative and anti-metastatic effects of urolithin A and urolithin B against esophageal cancer cells: an in vitro and in silico study. DARU Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-025-00570-1

Vancouver

Shojaee M, Rostami M, Soukhtanloo M, Jalili-Nik M. Evaluation and comparison of the anti-proliferative and anti-metastatic effects of urolithin A and urolithin B against esophageal cancer cells: an in vitro and in silico study. DARU Journal of Pharmaceutical Sciences. 2025. doi:10.1007/s40199-025-00570-1

BibTeX
@article{Shojaee2025,
  author = {Shojaee, Maryam and Rostami, Mehdi and Soukhtanloo, Mohammad and Jalili-Nik, Mohammad},
  title = {Evaluation and comparison of the anti-proliferative and anti-metastatic effects of urolithin A and urolithin B against esophageal cancer cells: an in vitro and in silico study},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2025},
  doi = {10.1007/s40199-025-00570-1}
}
Kostenlos starten →